Learning Objectives:

1. To learn that somatic tumor sequencing panels frequently identify patients at risk for hereditary hematopoietic malignancies despite not being designed for this purpose.

2. To understand the role of unbiased sequencing studies for syndrome discovery in the field of hereditary hematopoietic disorders.

3. To learn about the role of clonal hematopoiesis as a potential risk factor for clinical progression in patients with hereditary hematopoietic disorders.


Session date: 
01/08/2018 - 12:00pm to 1:00pm CST
University of Chicago Medicine
5841 South Maryland Avenue
MC2115, Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael W. Drazer, MD